Pathology
|
Find a Doctor
Gregory Lauwers, MD
Program: Pathology
Overview
Cancer Focus: Anal Cancer, Appendiceal (Appendix) Cancer, Cholangiocarcinoma (Bile Duct Cancer), Colon Cancer, Colorectal Cancer, Esophageal Cancer, Gallbladder Cancer, Gastrointestinal Carcinoid Tumor, GIST (Gastrointestinal Stromal Tumor), Liver Cancer, Neuroendocrine Tumor, Pancreatic Cancer, Rectal Cancer, Small Intestine Cancer, Stomach (Gastric) Cancer Dr. Gregory Lauwers is a Senior Member in Anatomic Pathology at Moffitt Cancer Center. Dr. Lauwers received his MD from the University of Paris, France. He completed a Surgical Pathology Residency at Lenox Hill Hospital, New York, NY and a Fellowship in Oncologic Pathology at Memorial Sloan-Kettering Cancer Center, where he also served as Chief Fellow. Following his Fellowship, Dr. Lauwers was in the Division of Anatomic Pathology, Department of Pathology at the University of Florida. From 2000 to 2016, Dr. Lauwers was in the Department of Pathology at Harvard Medical School and also served as Director, Gastrointestinal Pathology Service and Vice Chair, Department of Pathology at Massachusetts General Hospital. He most recently has been a Professor in the Department of Pathology at the University of California San Francisco. He is currently adjunct Professor of Pathology at Pusan National University, School of Medicine, Pusan, Korea and Clinical Professor at the School of Pathology and Laboratory Medicine, at the University of Western Australia, in Perth. Dr. Lauwers has published over 350 peer-reviewed articles, editorials, reviews, and book chapters, and is coauthor of several textbooks, including the 5th edition of Morson and Dawson's Gastrointestinal Pathology and Advances in Surgical Pathology: Gastric Cancer. Dr. Lauwers serves on the editorial boards of several journals, he is Deputy Editor-in-Chief of the Archives of Pathology and Laboratory Medicine, and he contributed to the WHO Classification of Tumours of the Digestive System (2010). Dr. Lauwers’ areas of clinical focus include luminal malignancies of the gut (particularly esophageal and gastric adenocarcinoma) and hepatocellular carcinoma. He is particularly interested in refining the pathologic assessment of new diagnostic and therapeutic modalities, closely collaborating with gastroenterologists, surgeons, oncologists and radiation oncologists. His research focuses predominantly on pre-neoplastic lesions and early cancers of the gut and particularly Barrett's esophagus-related neoplasms and gastric cancer. More specifically his interests are: 1) to refine diagnostic criteria and to bridge the traditional morphologic classifications with the novel molecular taxonomy in order to improve prognostication and enhance targeted therapies; and 2) to evaluate the diagnostic capabilities of new imaging modalities (optical coherent tomography, confocal laser endomicroscopy) in the screening and surveillance of patients. He is focused on support of the GI pathology service; further developing outreach, applying the latest advances in molecular diagnostics to clinical diagnostics, and participating in translational research. Education & TrainingFellowship:
Residency:
Medical School:
Participating Trials
If you believe you are eligible for one of these trials or studies, please call
Publications
Patient Comments
Overall Satisfaction
0
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Comments ()Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy. We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic. Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months. Learn more about our patient commentsProvider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
|
Request an Appointment at Moffitt Cancer Center
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub
